Vanda Pharmaceuticals
VNDA
VNDA
179 hedge funds and large institutions have $867M invested in Vanda Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 60 increasing their positions, 72 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
179
Holders Change
+12
Holders Change %
+7.19%
% of All Funds
3.53%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
28
Increased
60
Reduced
72
Closed
11
Calls
$738K
Puts
$3.55M
Net Calls
-$2.81M
Net Calls Change
-$1.93M
Top Buyers
| 1 |
WG
Winton Group
London,
United Kingdom
|
$9.07M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
$20.8M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
$50.8M |
| 4 |
BlackRock
New York
|
$154M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
$4.24M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
$46.4M |
| 2 |
Millennium Management
New York
|
$223K |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$1.71M |
| 4 |
State Street
Boston,
Massachusetts
|
$41.6M |
| 5 |
Goldman Sachs
New York
|
$11M |
